Scientists at The Ohio State University developed the brain, about the size of a pencil eraser, which has an identifiable structure and contains 99 per cent of the genes present in the human foetal brain.
"The brain organoid, engineered from adult human skin cells, is the most complete human brain model yet developed," said Rene Anand, professor of biological chemistry and pharmacology at Ohio State.
Such a system will enable ethical and more rapid and accurate testing of experimental drugs before the clinical trial stage and advance studies of genetic and environmental causes of central nervous system disorders.
"We've struggled for a long time trying to solve complex brain disease problems that cause tremendous pain and suffering. The power of this brain model bodes very well for human health because it gives us better and more relevant options to test and develop therapeutics other than rodents," he said.
Anand said the main thing missing in this model is a vascular system. A spinal cord, all major regions of the brain, multiple cell types, signalling circuitry and even a retina are present and have the potential to dramatically accelerate the pace of neuroscience research.
"We provide the best possible environment and conditions that replicate what's going on in utero to support the brain," he said of the work he completed with colleague Susan McKay, a research associate in biological chemistry and pharmacology.
High-resolution imaging of the organoid identifies functioning neurons and their signal-carrying extensions - axons and dendrites - as well as astrocytes, oligodendrocytes and microglia.
The model also activates markers for cells that have the classic excitatory and inhibitory functions in the brain, and that enable chemical signals to travel throughout the structure.
"If we let it go to 16 or 20 weeks, that might complete it, filling in that 1 per cent of missing genes. We don't know yet," he said.
He and McKay have already used the platform to launch their own projects, creating brain organoid models of Alzheimer's and Parkinson's diseases and autism in a dish.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
